Prostate Cancer in the Transgender Community

Photo Credit: Franziska Neumeister https://www.flickr.com/photos/127085184@N05/This section of our website has been designed to provide information about prostate cancer for male-to-female (MTF) individuals and their health care providers. For clarity we will refer to these individuals as transgender women, or trans women, but recognize that many individuals identify along a spectrum and may not choose to identify in this manner.
  • Transgender women have a prostate and it is possible for them to develop prostate cancer, regardless of whether or not they have undergone gender-confirming surgery.
  • The decision to screen for prostate cancer, and how to do so, should be made by the patient in the context of a dedicated care-discussion with their healthcare provider including risk factors, such as having a family history of prostate cancer or being of African or Caribbean decent, and taking into account the fact that prostate cancer screening may be considered not gender affirming for some transgender women, and may be both physically and emotionally painful.
  • There are limited reports of prostate cancer in trans women and Prostate Cancer Canada encourages more research in this area to gain a better understanding of population level risk and the personal experience of trans women undergoing testing, diagnosis and treatment of prostate cancer.
 

Why is it
important?

Should I
get tested?

Resources

For trans women experiencing prostate cancer, Prostate Cancer UK is trialling an online community support group. More information can be found here.
 
Definitions are adapted from: Provincial Health Services Authority (PHSA), Transgender Health Information Program, Glossary. Available here.

QMUNITY, Queer Terminology from A to Q. Available here.








Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive